SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting stellar positive Phase 2 results for sonelokimab in axial spondyloarthritis, which the community views as potentially best-in-class with deep biologic activity. High anticipation for its upcoming Investor Day, coupled with significant institutional re-accumulation and existing short interest, is fueling widespread discussion of the stock's undervaluation and potential for a substantial rally or even a buyout.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN crypto token is trending, frequently confused with the highly controversial Mullen Automotive stock, leading to a polarized community discussion; while a small group attempts to rally a "Mullen Army" with claims of utility, the broader sentiment warns of it being a "scam coin" with extremely low volume and potential for further decline.

We're a deflationary token that builds utility around our BTC and ETH reserves.  Our main goal is to onboard newbies in the friendliest and safest way, that's why we launched our NFT book (definitely for dummies) on five chains one year ago.  Our new swap generates revenue that combined with our taxes allow us to grow at a slow but steady pace; We're completely sustainable because our monthly expenses are really low.

PiggyCoinBSC

PiggyCoinBSC ($PIGGYC) is trending as its community actively engages in X spaces, highlighting its unique tokenomics that include $BTC and $ETH strategic reserves, and the utility of its new multi-chain swap platform, Swappy. Despite strong bullish sentiment from supporters, some community members are voicing concerns and labeling it a scam.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as a Supreme Court decision to strike down prior tariffs prompted an immediate announcement of new, 15% global tariffs. This has ignited community debate over potential inflationary pressures and consumer financial impacts, linking the company to broader economic policy discussions.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is seeing significant buzz driven by its recent multiple exchange listings and robust AI agent utility on the Base ecosystem, with the community actively discussing its strong revenue generation and potential for substantial growth, often contrasting its performance with broader crypto market trends.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF (XOP) is heavily discussed as escalating geopolitical tensions, including potential disruptions in the Strait of Hormuz and new US sanctions on major Russian oil entities, fuel concerns about global energy supply. Community sentiment is sharply divided, with some anticipating a significant oil price surge from tight inventories while others contend prices are being deliberately suppressed despite strong underlying demand.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA approval of BYSANTI, its second major drug approval in two months, igniting widespread community speculation about its long-term revenue potential and a significant buyout from major pharmaceutical companies seeking to fill patent cliffs, especially given the anticipated blockbuster impact of its Tradipitant pipeline.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is trending amid a strategic pivot to AI/HPC cloud services and data center expansion, supported by solid Q4 revenue and a large capital raise; however, the community is actively debating the impact of this substantial dilution and the sale of all its Bitcoin holdings, leading to significant stock volatility.

Gildan Activewear, Inc. engages in the manufacture and sale of print wear and branded apparel. Its products include activewear, underwear, socks, hosiery, and legwear. The firm operates under the brand names Gildan, Alstyle, American Apparel, Comfort Colors, GOLD TOE, Anvil, Secret, Silks, and Peds. The company was founded by Glenn J. Chamandy and H. Gregory Chamandy on May 8, 1984 and is headquartered in Montreal, Canada.

Gildan Activewear Inc

The strategic acquisition of HanesBrands is a major catalyst for Gildan Activewear, with the community viewing it as a transformative move to create an apparel powerhouse and unlock significant cost synergies. Concurrently, investor discussions are heavily focused on the recent boardroom changes and the return of former CEO Glenn Chamandy, influencing market sentiment around the company's future direction.

VanEck ETF Trust - VanEck Agribusiness ETF

VanEck Agribusiness ETF

The VanEck Agribusiness ETF ($MOO) is trending as the community highlights a multi-year base breakout, signaling a rotation into the long-unloved agriculture sector. Many believe commodities, tied to essential food demand, are poised for significant outperformance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Isthmus Partners LLC Acquires 16,505 Shares of Haemonetics Corporation $HAE

Isthmus Partners LLC lifted its holdings in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 36.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference PR Newswire BOSTON, Feb...

Haemonetics Corporation (NYSE:HAE) Given Average Rating of "Moderate Buy" by Brokerages

Haemonetics Corporation (NYSE:HAE - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are presently covering the firm, Marketbeat.com...

Haemonetics Corporation $HAE Stock Holdings Lessened by Heartland Advisors Inc.

Heartland Advisors Inc. reduced its stake in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 38.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with...

ABN Amro Investment Solutions Buys Shares of 200,000 Haemonetics Corporation $HAE

ABN Amro Investment Solutions purchased a new position in Haemonetics Corporation (NYSE:HAE - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...

Short Interest in Haemonetics Corporation (NYSE:HAE) Decreases By 21.7%

Haemonetics Corporation (NYSE:HAE - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 2,411,300...

Haemonetics Corporation $HAE Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. reduced its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 11.6% during the 3rd quarter, according to the company in its most recent filing with the SEC...

Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE

Skylands Capital LLC grew its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 195.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 81,369 shares...

Haemonetics (HAE) International Revenue Performance Explored

Evaluate Haemonetics' (HAE) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

HAE
Haemonetics Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HAE News

HAEHaemonetics Corp.